Latest News

Filters

Filter by tags: Radiopharmaceutical Clear all tag filters

32 news articles found


China Isotope & Radiation Corporation (CIRC) has won a contract to construct a gamma irradiation facility at the Bangladesh Institute of Nuclear Agriculture (BINA).

Date: Tuesday, 18 June 2024
Original article: world-nuclear-news.org/Articles/China-to-supply-Bangladesh-with-irradiation-plant

A second isotope production line is being installed at Bruce 7 to double its production capacity to meet forecast increases in demand. Bruce Power and Saugeen Ojibway Nation have also announced an expansion of their partnership for the production of and marketing of medical radioisotopes.

Date: Thursday, 30 May 2024
Original article: world-nuclear-news.org/Articles/Bruce-Power-and-partners-to-expand-isotope-capacit

Russia's Rosatom has signed agreements relating to developing nuclear medicine centres in Nicaragua and Kazakhstan, and also a memorandum of understanding with Burkina Faso which includes potential nuclear energy projects.

Date: Wednesday, 27 March 2024
Original article: world-nuclear-news.org/Articles/Agreements-Burkina-Faso,-Nicaragua-and-Kazakhstan

Orano Med (a subsidiary of the Orano Group) has laid the foundation stone for its ATLab (Alpha Therapy Laboratory) in Onnaing, France. This will be Europe's first industrial-scale pharmaceutical facility dedicated to the production of lead-212 (Pb-212) based radioligand therapies.

Date: Saturday, 10 February 2024
Original article: neimagazine.com/news/newsorano-med-breaks-ground-for-new-alpha-therapy-laboratory-11502059

Orano subsidiary Orano Med has laid the foundation stone for its Alpha Therapy Laboratory (ATLab) in Onnaing in northern France. This will be Europe's first industrial-scale pharmaceutical facility dedicated to the production of lead-212 (Pb-212) based radioligand therapies.

Date: Wednesday, 07 February 2024
Original article: world-nuclear-news.org/Articles/Construction-starts-on-French-lead-212-production

Germany-based radiopharmaceutical biotech company ITM Isotope Technologies Munich SE and Canadian Nuclear Laboratories (CNL) have launched Actineer, a joint venture for the industrial-scale production of actinium-225 (Ac-225).

Date: Friday, 20 October 2023
Original article: world-nuclear-news.org/Articles/CNL,-ITM-join-up-to-produce-rare-medical-radioisot

Kyrgyzstan's Ministry of Health and Rosatom are working together on a new nuclear medicine diagnostic centre at the National Centre for Oncology and Haematology in Bishkek, with the latest stage being the delivery of a technetium-99m GT-4K generator.

Date: Friday, 04 August 2023
Original article: world-nuclear-news.org/Articles/Nuclear-medicine-project-in-Kyrgyzstan-making-prog

US-based TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK-CEN and IBA, have launched a strategic collaboration intended to increase the availability of Actinium-225, a radioisotope used to target and treat cancer.

Date: Saturday, 01 July 2023
Original article: neimagazine.com/news/newsterrapower-and-pantera-to-collaborate-on-actinium-225-10978704

TerraPower Isotopes and Belgian joint venture PanTera have announced a collaboration to increase the global availability of actinium-225 (Ac-225), while Arizona-based Serva Energy has developed a new research reactor-based production method to ramp up the supply of the rare radioisotope.

Date: Wednesday, 28 June 2023
Original article: world-nuclear-news.org/Articles/Nuclear-innovation-companies-in-new-Ac-225-initiat